Clinical Trial Update: Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating a soluble epoxide hydrolase inhibitor for subarachnoid hemorrhage with delayed cerebral ischemia has completed enrollment and poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Vasospasm
• Delayed Cerebral Ischemia
• Endothelial Dysfunction
• Subarachnoid Hemorrhage

Drugs mentioned

• Soluble epoxide hydrolase inhibitor

Snippet

Sponsor: Oregon Health and Science University | Conditions: Subarachnoid Hemorrhage, Aneurysmal, Delayed Cerebral Ischemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-01-22